Ewa Krawczyk

Dr. Ewa Krawczyk

Pathology, Georgetown University Medical Center, Washington D.C., USA
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2017 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
XLXuefeng Liu
Xuefeng Liu
EKEwa Krawczyk
Ewa Krawczyk
FSFrank A Suprynowicz
Frank A Suprynowicz
NPNancy Palechor-Ceron
Nancy Palechor-Ceron
HYHang Yuan
Hang Yuan
RSRichard Schlegel
Richard Schlegel

19 November 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
FSFrank A. Suprynowicz
Frank A. Suprynowicz
GUGeeta Upadhyay
Geeta Upadhyay
EKEwa Krawczyk
Ewa Krawczyk
SKSarah C. Kramer
Sarah C. Kramer
JHJess D. Hebert
Jess D. Hebert
RSRichard Schlegel
Richard Schlegel
The combination of irradiated fibroblast feeder cells and Rho kinase inhibitor, Y-27632, conditionally induces an indefinite proliferative state in primary mammalian epithelial cells. These conditionally reprogrammed cells (CRCs) are karyotype-stable and nontumorigenic. Because self-renewal is a recognized property of stem cells, we investigated whether Y-27632 and feeder cells induced a stem-like phenotype. We found that CRCs share characteristics of adult stem cells and exhibit up-regulated expression of α6 and β1 integrins, ΔNp63α, CD44, and telomerase reverse transcriptase, as well as decreased Notch signaling and an increased level of nuclear β-catenin. The induction of CRCs is rapid (occurs within 2 d) and results from reprogramming of the entire cell population rather than the selection of a minor subpopulation. CRCs do not overexpress the transcription factor sets characteristic of embryonic or induced pluripotent stem cells (e.g., Sox2, Oct4, Nanog, or Klf4). The induction of CRCs is also reversible, and removal of Y-27632 and feeders allows the cells to differentiate normally. Thus, when CRCs from ectocervical epithelium or tracheal epithelium are placed in an air–liquid interface culture system, the cervical cells form a well differentiated stratified squamous epithelium, whereas the tracheal cells form a ciliated airway epithelium. We discuss the diagnostic and therapeutic opportunities afforded by a method that can generate adult stem-like cells in vitro without genetic manipulation.

1 September 2008 in The American Journal of Pathology
Verified
Journal Article
Closed access
EKEwa Krawczyk
Ewa Krawczyk
FSFrank A. Suprynowicz
Frank A. Suprynowicz
XLXuefeng Liu
Xuefeng Liu
YDYuhai Dai
Yuhai Dai
DHDan P. Hartmann
Dan P. Hartmann
RSRichard Schlegel
Richard Schlegel

8 July 2023 in Journal of Biological Chemistry
Verified
Journal Article
Open access
Komuraiah MyakalaKomuraiah Myakala
Komuraiah Myakala
Xiaoxin WangXiaoxin Wang
Xiaoxin Wang
NSNataliia V. Shults
Nataliia V. Shults
EKEwa Krawczyk
Ewa Krawczyk
BJBryce A. Jones
Bryce A. Jones
MLMoshe Levi
Moshe Levi
Diabetes mellitus is the leading cause of cardiovascular and renal disease in the United -States. Despite the beneficial interventions available for patients with diabetes, there remains a need for additional therapeutic targets and therapies in diabetic kidney disease (DKD). Inflammation and oxidative stress are increasingly recognized as important causes of renal diseases. Inflammation is closely associated with mitochondrial damage. The molecular connection between inflammation and mitochondrial metabolism remains to be elucidated. Recently, nicotinamide adenine nucleotide (NAD+) metabolism has been found to regulate immune function and inflammation. In the present studies, we tested the hypothesis that enhancing NAD metabolism could prevent inflammation in and progression of DKD. We found that treatment of db/db mice with type 2 diabetes with nicotinamide riboside (NR) prevented several manifestations of kidney dysfunction (i.e., albuminuria, increased urinary kidney injury marker-1 (KIM1) excretion, and pathologic changes). These effects were associated with decreased inflammation, at least in part via inhibiting the activation of the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) signaling pathway. An antagonist of the serum stimulator of interferon genes (STING) and whole-body STING deletion in diabetic mice showed similar renoprotection. Further analysis found that NR increased SIRT3 activity and improved mitochondrial function, which led to decreased mitochondrial DNA damage, a trigger for mitochondrial DNA leakage which activates the cGAS-STING pathway. Overall, these data show that NR supplementation boosted NAD metabolism to augment mitochondrial function, reducing inflammation and thereby preventing the progression of diabetic kidney disease.

31 January 2006 in Medical Microbiology and Immunology
Verified
Journal Article
Closed access
PDF file
APAnna Przerwa
Anna Przerwa
MZMichał Zimecki
Michał Zimecki
KŚKinga Świtała-Jeleń
Kinga Świtała-Jeleń
KDKrystyna Dąbrowska
Krystyna Dąbrowska
EKEwa Krawczyk
Ewa Krawczyk
AGAndrzej Górski
Andrzej Górski

27 October 2019 in Cells
Verified
Journal Article
Open access
PDF file
NPNancy Palechor-Ceron
Nancy Palechor-Ceron
EKEwa Krawczyk
Ewa Krawczyk
ADAleksandra Dakic
Aleksandra Dakic
VSVera Simic
Vera Simic
HYHang Yuan
Hang Yuan
XLXuefeng Liu
Xuefeng Liu
Traditional cancer models including cell lines and animal models have limited applications in both basic and clinical cancer research. Genomics-based precision oncology only help 2–20% patients with solid cancer. Functional diagnostics and patient-derived cancer models are needed for precision cancer biology. In this review, we will summarize applications of conditional cell reprogramming (CR) in cancer research and next generation living biobanks (NGLB). Together with organoids, CR has been cited in two NCI (National Cancer Institute, USA) programs (PDMR: patient-derived cancer model repository; HCMI: human cancer model initiatives. HCMI will be distributed through ATCC). Briefly, the CR method is a simple co-culture technology with a Rho kinase inhibitor, Y-27632, in combination with fibroblast feeder cells, which allows us to rapidly expand both normal and malignant epithelial cells from diverse anatomic sites and mammalian species and does not require transfection with exogenous viral or cellular genes. Establishment of CR cells from both normal and tumor tissue is highly efficient. The robust nature of the technique is exemplified by the ability to produce 2 × 106 cells in five days from a core biopsy of tumor tissue. Normal CR cell cultures retain a normal karyotype and differentiation potential and CR cells derived from tumors retain their tumorigenic phenotype. CR also allows us to enrich cancer cells from urine (for bladder cancer), blood (for prostate cancer), and pleural effusion (for non-small cell lung carcinoma). The ability to produce inexhaustible cell populations using CR technology from small biopsies and cryopreserved specimens has the potential to transform biobanking repositories (NGLB: next-generation living biobank) and current pathology practice by enabling genetic, biochemical, metabolomic, proteomic, and biological assays, including chemosensitivity testing as a functional diagnostics tool for precision cancer medicine. We discussed analyses of patient-derived matched normal and tumor models using a case with tongue squamous cell carcinoma as an example. Last, we summarized applications in cancer research, disease modeling, drug discovery, and regenerative medicine of CR-based NGLB.